{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T18:47:24Z","timestamp":1774810044785,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.mehy.2017.05.036","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T05:46:43Z","timestamp":1496382403000},"page":"121-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Calcium-channel blockers as therapeutic agents for acquired sensorineural hearing loss"],"prefix":"10.1016","volume":"104","author":[{"given":"James G.","family":"Naples","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2017.05.036_b0005","unstructured":"Quick Statistics about Hearing. Dec 15, 2016. Available at: <https:\/\/www.nidcd.nih.gov\/health\/statistics\/quick-statistics-hearing>."},{"key":"10.1016\/j.mehy.2017.05.036_b0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S0022215113000947","article-title":"Mechanisms of cisplatin ototoxicity: theoretical review","volume":"127","author":"Goncalves","year":"2013","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.mehy.2017.05.036_b0015","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/sj.bjp.0707405","article-title":"The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear","volume":"152","author":"Garcia-Berrocal","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2017.05.036_b0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0030-6665(20)30770-2","article-title":"Ototoxicity of loop diuretics","volume":"26","author":"Rybak","year":"1993","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.mehy.2017.05.036_b0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.heares.2009.10.009","article-title":"Age-related loss of spiral ganglion neurons","volume":"264","author":"Bao","year":"2010","journal-title":"Hear Res"},{"key":"10.1016\/j.mehy.2017.05.036_b0030","series-title":"M\u00e9ni\u00e8re's disease: evidence and outcomes","author":"Ruckenstein","year":"2010"},{"key":"10.1016\/j.mehy.2017.05.036_b0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MOO.0000000000000289","article-title":"Current concepts in the management of idiopathic sudden sensorineural hearing loss","volume":"24","author":"O'Connell","year":"2016","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.mehy.2017.05.036_b0040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.otc.2012.06.002","article-title":"Evidence-based practice: management of adult sensorineural hearing loss","volume":"45","author":"Chau","year":"2012","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.mehy.2017.05.036_b0045","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s00405-012-2029-0","article-title":"Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models","volume":"269","author":"Casares","year":"2012","journal-title":"Eur Arch Oto-rhino-laryngol"},{"key":"10.1016\/j.mehy.2017.05.036_b0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention","volume":"226","author":"Rybak","year":"2007","journal-title":"Hear Res"},{"key":"10.1016\/j.mehy.2017.05.036_b0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0378-5955(95)00010-2","article-title":"Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro","volume":"84","author":"Clerici","year":"1995","journal-title":"Hear Res"},{"key":"10.1016\/j.mehy.2017.05.036_b0060","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S1359-6446(05)03552-X","article-title":"Ototoxicity: therapeutic opportunities","volume":"10","author":"Rybak","year":"2005","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.mehy.2017.05.036_b0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0736-5748(99)00094-5","article-title":"Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies","volume":"18","author":"Huang","year":"2000","journal-title":"Int J Develop Neurosci"},{"key":"10.1016\/j.mehy.2017.05.036_b0070","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrm1150","article-title":"Regulation of cell death: the calcium-apoptosis link","volume":"4","author":"Orrenius","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.mehy.2017.05.036_b0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/00016489309135781","article-title":"Effects of free radicals on the intracellular calcium concentration in the isolated outer hair cell of the guinea pig cochlea","volume":"113","author":"Ikeda","year":"1993","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.mehy.2017.05.036_b0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.heares.2005.01.011","article-title":"Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells","volume":"204","author":"So","year":"2005","journal-title":"Hear Res"},{"key":"10.1016\/j.mehy.2017.05.036_b0085","article-title":"Cisplatin-Induced Ototoxicity and the Effects of Intratympanic Diltiazem in a Mouse Model","author":"Naples","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.mehy.2017.05.036_b0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.heares.2013.06.004","article-title":"Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss","volume":"304","author":"Bao","year":"2013","journal-title":"Hear Res"},{"key":"10.1016\/j.mehy.2017.05.036_b0095","series-title":"Basic & clinical pharmacology McGraw-Hill's Access Medicine","volume":"xiii, 1","author":"Katzung","year":"2012"},{"key":"10.1016\/j.mehy.2017.05.036_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1620\/tjem.218.41","article-title":"L-type voltage-gated calcium channel is involved in the pathogenesis of acoustic injury in the cochlea","volume":"218","author":"Uemaetomari","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.mehy.2017.05.036_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.heares.2013.02.002","article-title":"Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity","volume":"299","author":"Waissbluth","year":"2013","journal-title":"Hear Res"},{"key":"10.1016\/j.mehy.2017.05.036_b0110","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1038\/sj.onc.1207105","article-title":"Calcium and apoptosis: facts and hypotheses","volume":"22","author":"Rizzuto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.mehy.2017.05.036_b0115","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/MAO.0b013e31818599d5","article-title":"Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections","volume":"29","author":"Hill","year":"2008","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.mehy.2017.05.036_b0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1227\/01.neu.0000279728.98273.51","article-title":"The influence of prophylactic vasoactive treatment on cochlear and facial nerve functions after vestibular schwannoma surgery: a prospective and open-label randomized pilot study","volume":"61","author":"Scheller","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.mehy.2017.05.036_b0125","first-page":"577","article-title":"Use of nimodipine in the medical treatment of Meniere's disease: clinical experience","volume":"17","author":"Lassen","year":"1996","journal-title":"Am J Otol"},{"key":"10.1016\/j.mehy.2017.05.036_b0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000058304","article-title":"Mechanisms of cell death in the injured auditory system: otoprotective strategies","volume":"7","author":"Lefebvre","year":"2002","journal-title":"Audiol Neuro-Otol"},{"key":"10.1016\/j.mehy.2017.05.036_b0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1288\/00005537-196007000-00002","article-title":"Vasodilator therapy in sensory-neural hearing loss","volume":"70","author":"Sheehy","year":"1960","journal-title":"Laryngoscope"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771730467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771730467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T07:28:52Z","timestamp":1602228532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771730467X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":27,"alternative-id":["S030698771730467X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2017.05.036","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcium-channel blockers as therapeutic agents for acquired sensorineural hearing loss","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2017.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}